LLAE also significantly reduced visceral fat mass, decreased fasting serum insulin levels and ameliorated insulin resistance in HFD-induced obese rats, indicating the anti-obesity and anti-diabetic activity of LLAE. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.